Literature DB >> 3114679

Hepatic vascular disease after kidney transplantation: report of two cases and review of the literature.

M Adler, M Delhaye, C Deprez, N Hardy, M Gelin, L De Pauw, P Vereerstraeten, M Cremer, C Toussaint.   

Abstract

Severe hepatic vascular disease developed in two patients 4 and 8 years after kidney transplantation, while receiving combined immunosuppressive therapy with prednisone and azathioprine. Portal hypertension and marked liver failure were observed in both cases. The diagnosis was established by histological examination of liver biopsies showing typical veno-occlusive disease of the liver associated with peliosis in both cases. Azathioprine was discontinued. Two years later one patient was asymptomatic and liver function tests were normal. The second patient died 3 years later from liver failure. Early recognition of hepatic vascular disease arising in kidney transplant recipients would be of utmost importance, as substitution of another immunosuppressive agent for azathioprine could halt the process leading to portal hypertension.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114679

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

1.  Venoocclusive disease of the liver following renal transplantation.

Authors:  M A Jeffries; W M McDonnell; J A Tworek; R M Merion; R H Moseley
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

2.  Idiopathic portal hypertension in a renal transplant patient after long-term azathioprine therapy.

Authors:  R Lorenz; M Brauer; M Classen; N Tornieporth; K Becker
Journal:  Clin Investig       Date:  1992-02

Review 3.  Psoriatic arthritis associated with peliosis hepatis: characteristics and therapeutic management.

Authors:  Maroua Slouma; Yasmine Khrifech; Rim Dhahri; Emna Hannech; Zeineb Tayeb; Amen Ghozzi; Leila Metoui; Imen Gharsallah; Bassem Louzir
Journal:  Clin Rheumatol       Date:  2021-02-17       Impact factor: 2.980

Review 4.  Prevention and management of the adverse effects associated with immunosuppressive therapy.

Authors:  S J Rossi; T J Schroeder; S Hariharan; M R First
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.